Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today ...
One recent obstacle to drug delivery research is an observed weak correlation between in vitro and in vivo performance. When nanoparticles are applied intravenously, they face several obstacles that ...
The Association for Molecular Pathology (AMP) has published a set of 13 best practice recommendations for validating and reporting clinical circulating tumor DNA (ctDNA) or liquid biopsy assays and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results